Trademark: 97482200
Word
METAGENOMI
Status
Pending
Status Code
731
Status Date
Thursday, June 6, 2024
Serial Number
97482200
Mark Type
4
Filing Date
Wednesday, June 29, 2022
Published for Opposition
Tuesday, May 16, 2023

Trademark Owner History
METAGENOMI, INC. - Owner At Publication

Classifications
5 Therapeutic pharmaceuticals for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic immunological, infectious, inflammatory, menopausal, metabolic, autoimmune, musculoskeletal, neurological, ophthalmological, psychiatric, respiratory, urogenital, urological, hematologic and viral diseases and disorders, as well as cancer and transplant rejections
1 Biologically-derived industrial chemicals; engineered microbes for use in the production of industrial chemicals; microbes for use in the manufacture of therapeutics for application in human diseases, and agriculture and industrial enzymes

Trademark Events
Jul 2, 2022
New Application Entered
Jul 19, 2022
New Application Office Supplied Data Entered
Apr 12, 2023
Assigned To Examiner
Apr 12, 2023
Approved For Pub - Principal Register
Apr 26, 2023
Notification Of Notice Of Publication E-Mailed
May 16, 2023
Published For Opposition
May 16, 2023
Official Gazette Publication Confirmation E-Mailed
Jul 11, 2023
Noa E-Mailed - Sou Required From Applicant
Jul 18, 2023
Sou Teas Extension Received
Jul 18, 2023
Sou Extension 1 Filed
Jul 18, 2023
Sou Extension 1 Granted
Jul 20, 2023
Notice Of Approval Of Extension Request E-Mailed
Jun 6, 2024
Teas Change Of Correspondence Received
Jun 6, 2024
Applicant/Correspondence Changes (Non-Responsive) Entered
Jun 6, 2024
Teas Change Of Owner Address Received
Jun 6, 2024
Sou Teas Extension Received
Jun 7, 2024
Sou Extension 2 Granted
Jun 7, 2024
Sou Extension 2 Filed
Jun 13, 2024
Notice Of Approval Of Extension Request E-Mailed

Trademark Alertz updated from USPTO on 2030-01-24